StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3047% below fair value
$1.32−0.04 (-2.94%)

Close on Nov 16, 2026Market cap $6.07MP/E –Yield –

Biomerica operating margin

Operating margin is operating income as a percentage of revenue.

Biomerica's operating margin for the twelve months ending Aug 31, 2026 was -125.2%. For fiscal 2026 it was -119.5%, against -96.7% the year before. The highest annual figure on record is 8.3% in fiscal 2012.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2026May 31, 2026-119.5%−22.7
FY2025May 31, 2025-96.7%+20.9
FY2024May 31, 2024-117.6%+17.7
FY2023May 31, 2023-135.3%−111.3
FY2022May 31, 2022-24.0%+80.2
FY2021May 31, 2021-104.2%−63.2
FY2020May 31, 2020-41.0%+5.4
FY2019May 31, 2019-46.4%−19.8
FY2018May 31, 2018-26.6%−10.1
FY2017May 31, 2017-16.5%−0.4
FY2016May 31, 2016-16.1%−2.6
FY2015May 31, 2015-13.5%−4.8
FY2014May 31, 2014-8.7%−16.7
FY2013May 31, 20137.9%−0.4
FY2012May 31, 20128.3%+11.0
FY2011May 31, 2011-2.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Aug 31, 2026-97.0%−16.0
Q4 FY2026CQ2 2026May 31, 2026-175.2%+33.6
Q3 FY2026CQ1 2026Feb 28, 2026-131.5%−23.4
Q2 FY2026CQ4 2025Nov 30, 2025-113.5%−52.8
Q1 FY2026CQ3 2025Aug 31, 2025-81.0%−5.3
Q4 FY2025CQ2 2025May 31, 2025-208.8%−71.9
Q3 FY2025CQ1 2025Feb 28, 2025-108.1%+88.5
Q2 FY2025CQ4 2024Nov 30, 2024-60.7%+41.9
Q1 FY2025CQ3 2024Aug 31, 2024-75.7%−3.8
Q4 FY2024CQ2 2024May 31, 2024-136.9%+28.8
Q3 FY2024CQ1 2024Feb 29, 2024-196.7%−48.1
Q2 FY2024CQ4 2023Nov 30, 2023-102.6%+9.8
Q1 FY2024CQ3 2023Aug 31, 2023-71.9%+54.5
Q4 FY2023CQ2 2023May 31, 2023-165.7%−132.6
Q3 FY2023CQ1 2023Feb 28, 2023-148.6%−147.2
Q2 FY2023CQ4 2022Nov 30, 2022-112.4%−88.1
Q1 FY2023CQ3 2022Aug 31, 2022-126.5%−4.4
Q4 FY2022CQ2 2022May 31, 2022-33.1%+130.3
Q3 FY2022CQ1 2022Feb 28, 2022-1.4%+58.3
Q2 FY2022CQ4 2021Nov 30, 2021-24.3%+100.5
Q1 FY2022CQ3 2021Aug 31, 2021-122.1%+44.0
Q4 FY2021CQ2 2021May 31, 2021-163.4%−133.1
Q3 FY2021CQ1 2021Feb 28, 2021-59.7%+18.1
Q2 FY2021CQ4 2020Nov 30, 2020-124.8%−94.1
Q1 FY2021CQ3 2020Aug 31, 2020-166.1%−123.4
Q4 FY2020CQ2 2020May 31, 2020-30.3%+35.3
Q3 FY2020CQ1 2020Feb 29, 2020-77.7%−21.7
Q2 FY2020CQ4 2019Nov 30, 2019-30.7%+1.7
Q1 FY2020CQ3 2019Aug 31, 2019-42.7%−6.9
Q4 FY2019CQ2 2019May 31, 2019-65.6%−8.6
Q3 FY2019CQ1 2019Feb 28, 2019-56.1%−32.6
Q2 FY2019CQ4 2018Nov 30, 2018-32.4%−14.5
Q1 FY2019CQ3 2018Aug 31, 2018-35.7%−20.1
Q4 FY2018CQ2 2018May 31, 2018-57.0%−32.7
Q3 FY2018CQ1 2018Feb 28, 2018-23.5%−2.3
Q2 FY2018CQ4 2017Nov 30, 2017-17.9%−2.6
Q1 FY2018CQ3 2017Aug 31, 2017-15.6%–
Q4 FY2017CQ2 2017May 31, 2017-24.2%–
Q3 FY2017CQ1 2017Feb 28, 2017-21.2%–
Q2 FY2017CQ4 2016Nov 30, 2016-15.3%–

More Biomerica figures

See a number that looks wrong?